Allen Yang
Net worth: 644 070 $ as of 2024-04-29
Profile
Allen Yang worked as the Medical Director of Blincyto Clinical Research at Amgen, Inc. He then served as the Vice President of Clinical Research at Spectrum Pharmaceuticals, Inc. From 2019 to 2023, he held the position of Chief Medical Officer & Senior Vice President at Xencor, Inc. He also worked as the VP & Therapeutic Area Head of Hematology/Oncology at Jazz Pharmaceuticals Plc.
Dr. Yang holds a doctorate degree from the University of Southern California and an undergraduate degree from the University of California, Berkeley.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
XENCOR, INC.
0.05% | 2024-02-28 | 33,493 ( 0.05% ) | 644 070 $ | 2024-04-29 |
Former positions of Allen Yang
| Companies | Position | End |
|---|---|---|
| XENCOR, INC. | Chief Tech/Sci/R&D Officer | 2023-04-30 |
| AMGEN INC. | Corporate Officer/Principal | - |
| SPECTRUM PHARMACEUTICALS, INC. | Corporate Officer/Principal | - |
| JAZZ PHARMACEUTICALS PLC | Corporate Officer/Principal | 2018-12-31 |
Training of Allen Yang
| University of California, Berkeley | Undergraduate Degree |
| University of Southern California | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 4 |
|---|---|
| JAZZ PHARMACEUTICALS PLC | Health Technology |
| XENCOR, INC. | Health Technology |
| SPECTRUM PHARMACEUTICALS, INC. | Health Technology |
| AMGEN INC. | Health Technology |
- Stock Market
- Insiders
- Allen Yang
